The human stories behind the treat-all policy in eSwatini
Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women
Gonorrhoea testing and treatment in Europe: survey reveals better testing for gay men, but gaps in resistance testing
Drug-resistance or viral-load testing required before switch to dolutegravir in Togo
New European HIV guidelines cater for multiple needs
Dolutegravir recommended for all in new World Health Organization guidelines
Significant health gains from faster switching to second-line ART in sub-Saharan Africa
What works against self-stigma? First systematic review aims to find out
